Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Jiangsu Sidike New Materials Science & Technology Co., Ltd. (300806.SZ)
Suqian, CN
Jiangsu Sidike New Materials Science & Technology Co., Ltd. is a Chinese enterprise that specializes in the production and sale of advanced, multi-functional coating composite materials. Its comprehensive product line features a variety of offerings. These include protective films, particularly those designed for computer and smartphone screens, safeguarding devices from damage. The company also supplies electronic-grade adhesive materials, such as solutions for double-sided fixing and sealing applications. A significant part of its portfolio consists of functional coating materials, which are engineered for specific purposes like protection, electrical conduction, insulation, electromagnetic shielding, and precise marking. Finally, Jiangsu Sidike manufactures film packaging materials. Founded in 2006, the company's operations are headquartered in Suqian, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.66% | -13.50% | +2.59% | +37.48% | +173.81% | +147.63% | +396.22% | +292.57% | +360.22% | +1,580.35% | +1,580.35% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | +1 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+12.1% ★ Q1'26: +12.9% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+8.3% Q1'26: +50.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-0.5% Q1'26: -20.7% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+5.4% Q1'26: +5.5% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+3.2% Q1'26: +3.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+2.9% Q1'26: +5.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×4.94× Q1'26: 18.31× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.54B
est: 1.55B (-0.7%)
|
1.98B
est: 2.17B (-8.6%)
|
1.88B
est: 2.28B (-17.6%)
|
1.97B
est: 1.97B (-0.1%)
|
2.69B
est: 2.78B (-3.3%)
|
3.02B
est: 3.34B (-9.8%)
|
3.65B
3.31B – 3.99B
+9.1% YoY
|
4.20B
3.53B – 4.86B
+15.1% YoY
|
4.85B
4.40B – 5.30B
+15.5% YoY
|
| EBITDA |
243.92M
est: 267.27M (-8.7%)
|
323.19M
est: 373.94M (-13.6%)
|
355.84M
est: 392.62M (-9.4%)
|
336.19M
est: 339.47M (-1.0%)
|
484.11M
est: 503.93M (-3.9%)
|
610.80M
est: 605.37M (+0.9%)
|
660.44M
599.02M – 721.86M
+9.1% YoY
|
759.89M
638.61M – 881.16M
+15.1% YoY
|
877.81M
796.17M – 959.45M
+15.5% YoY
|
| EBIT |
150.67M
est: 127.43M (+18.2%)
|
231.82M
est: 178.28M (+30.0%)
|
196.36M
est: 187.19M (+4.9%)
|
94.08M
est: 161.85M (-41.9%)
|
117.54M
est: 204.38M (-42.5%)
|
164.10M
est: 245.52M (-33.2%)
|
267.86M
242.95M – 292.77M
+9.1% YoY
|
308.19M
259.01M – 357.38M
+15.1% YoY
|
356.02M
322.91M – 389.13M
+15.5% YoY
|
| Net Income |
181.63M
est: 177.46M (+2.3%)
|
209.94M
est: 275.88M (-23.9%)
|
168.09M
est: 273.87M (-38.6%)
|
56.07M
est: 130.81M (-57.1%)
|
54.88M
est: 92.85M (-40.9%)
|
60.35M
est: 83.56M (-27.8%)
|
188.00M
155.08M – 197.74M
+125.0% YoY
|
318.00M
255.07M – 325.22M
+69.1% YoY
|
438.70M
385.66M – 491.74M
+38.0% YoY
|
| SGA |
120.82M
est: 147.07M (-17.9%)
|
169.17M
est: 205.77M (-17.8%)
|
193.69M
est: 216.05M (-10.4%)
|
223.65M
est: 186.80M (+19.7%)
|
251.80M
est: 235.70M (+6.8%)
|
84.37M
est: 283.15M (-70.2%)
|
308.90M
280.18M – 337.63M
+9.1% YoY
|
355.42M
298.69M – 412.14M
+15.1% YoY
|
410.57M
372.39M – 448.76M
+15.5% YoY
|
| EPS |
0.43
est: 0.39 (+9.3%)
|
0.50
est: 0.61 (-18.2%)
|
0.39
est: 0.61 (-35.8%)
|
0.12
est: 0.29 (-58.6%)
|
0.12
est: 0.20 (-40.0%)
|
0.13
est: 0.18 (-27.8%)
|
0.38
0.33 – 0.43
+111.1% YoY
|
0.63
0.55 – 0.70
+64.5% YoY
|
0.95
0.83 – 1.06
+51.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.04% | 272.5K | 0.65% |
| 2 | Dimensional - Emerging Markets Value ETF DFEV | 0.01% | 227.9K | 0.46% |
| 3 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.01% | 528.3K | 0.39% |
| 4 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 382.4K | 0.29% |
| 5 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 316.3K | 0.28% |
| 6 | State Street SPDR S&P China ETF GXC | 0.00% | 7.4K | 0.59% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bi Yang | Deputy GM & Director | — | male |
| Chao Wang | Deputy General Manager | — | female |
| Chuang Jin | GM & Chairman of the Board | — | male |
| Feng Chen | Deputy GM & Director | — | male |
| Jiang Wu | Chief Financial Officer, Financial Director, Accounting Supervisor, Secretary to the Board & Director | — | male |
| Xiangqing Feng | Deputy General Manager | — | male |
| Zhangjian Jiang | Deputy General Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300806.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
